Skip to content
The Biotechnology Innovation Organization (BIO) hosted leaders from industry and governments in the U.S. and Africa in an effort to build collaboration against cancer […]
BIO hosts industry and government leaders in Africa Summit side event targeting cancer Read More »
The 2022 midterms are officially behind us – so, what happened, and what does biotech need to know going into the new year? We
2022 midterms recap: what happened and what the results mean for biotech Read More »
Dobbs v. Jackson has had a ripple effect across healthcare—from increasing the danger of medical management of miscarriages and risk of maternal mortality, to
How Dobbs v. Jackson is affecting vaccine innovation Read More »
“The pandemic has exposed our country’s dependence on other countries for essential prescription drugs,” began Steve Scully, contributing editor at The Hill and moderator
COVID-19 forced us to reimagine the pharma supply chain – and that’s a good thing Read More »
The U.S. was solely responsible for 61% of medicines approved by the U.S. Food and Drug Administration (FDA) between 2011-2020, says a new report
55% of FDA-approved drugs were developed by U.S. small biotechs, says study Read More »
This is a tough winter for respiratory disease. Coming off of a two-year pandemic we are finding that flu season now has a few
Fight the ‘tripledemic’ with vaccines, tests, and treatment Read More »
Paying for healthcare in the United States has been a challenging and controversial issue for years. In a landscape managed by private insurers, Medicaid,
To ensure access for all, healthcare payment models need innovation Read More »
Provisions in the Inflation Reduction Act (IRA) make it easier for people covered by Medicare Part D to pay for medicine, but continued government
CMS must flesh out plan to ease out-of-pocket drug costs, report says Read More »
Rachel King was enjoying her retirement. When the COVID-19 pandemic hit, King found herself with a chance to refocus and ask herself what was
Meet Rachel King, BIO’s new interim CEO and a champion of the biotech industry Read More »
What did we learn on Day 1 of the Biotechnology Innovation Organization (BIO) Patient and Health Advocacy Summit in Washington, D.C.? It’s all about
What we learned on Day 1 of the Patient and Health Advocacy Summit Read More »
